Eli Lilly
LLY
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 7 hours ago • LLY
Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?
The Motley Fool • 2 days ago • LLY
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026
Zacks Investment Research • 2 days ago • LLY
LLY Trading Above 50 & 200-Day SMAs for 2 Months: How to Play the Stock
Zacks Investment Research • 3 days ago • LLY
3 Large Drug Stocks to Watch as the Industry Shows Some Recovery
Forbes • 3 days ago • LLY
Companies Cut Prices For Blockbuster Weight-Loss Drugs
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.